Skip to content
Clinical Trials – home

Klinik Landstrasse

Verifiedinfo

Austria Juchgasse 25, Landstrasse, 1030 Vienna, Austria

  • 4 trials recruiting
  • Arteriosclerosis · Obesity · Metabolic dysfunction-associated steatohepatitis
  • Adult patients

About Specializations

Klinik Landstrasse in Vienna, Austria specialises in clinical trials of conditions such as Arteriosclerosis, Obesity, Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The research program at Klinik Landstrasse emphasizes innovative strategies to lower the risk of heart attacks, strokes, and related complications in patients with cardiovascular disease. Studies compare novel agents to standard care, aiming to improve outcomes for those with high lipid levels, elevated lipoprotein(a), and advanced arterial disease.

  • Acute Myocardial Infarction
  • Atherosclerotic Cardiovascular Disease
  • Elevated Lp(a)
  • Left Ventricular Hypertrophy
  • Adults at high risk of cardiovascular events without prior MI or stroke

With three dedicated investigators, the site conducts multiple trials to evaluate the safety and effectiveness of emerging cardiovascular therapies, supporting patients at high risk of recurrent events.

Digestive System Diseases

Clinical investigations target liver health, focusing on non-alcoholic steatohepatitis (NASH) and broader metabolic dysfunction-associated steatotic liver disease. The goal is to determine whether new treatments can improve liver histology and reduce progression to cirrhosis.

  • Metabolic Dysfunction-Associated Steatotic Liver Disease
  • Non-alcoholic steatohepatitis (NASH)

The department leverages its expertise in endocrinology and hepatology to advance therapeutic options for patients with fatty liver conditions.

Nutritional and Metabolic Diseases

Research at the site addresses the growing burden of obesity, overweight, and type 2 diabetes mellitus. Trials explore weight‑loss agents and glucose‑lowering drugs to achieve better metabolic control and reduce associated health risks.

  • Obesity
  • Overweight
  • Overweight and obesity and type 2 diabetes
  • Type 2 Diabetes Mellitus

By testing novel combinations and dose regimens, investigators aim to provide safer, more effective options for metabolic disease management.

Metabolism

The department’s metabolic research includes studies on kidney function and albuminuria, seeking therapies that protect renal health while modulating metabolic pathways.

  • Chronic Kidney Disease
  • Chronic Kidney Disease and Albuminuria
  • Hemodialysis
  • Kidney Failure

Through collaborative trials, the site evaluates how metabolic interventions can slow disease progression and improve quality of life for patients with renal impairment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Juchgasse 25, Landstrasse1030 ViennaAustria
Recruiting now
4 trials
Conditions studied
16
Partner status
Verified

More sites in ViennaAustria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

19 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Medical University Of Graz
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Medical University Of Vienna

Chronic kidney disease+3

Not yet recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Medical University Of Vienna
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Dyslipidaemia

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.